Ensysce Biosciences (ENSCW) Revenue (QoQ) (2020 - 2025)
Ensysce Biosciences (ENSCW) Revenue (QoQ) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ensysce Biosciences |
- |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-64.04% |
| Jun 30, 2025 |
3.91% |
| Mar 31, 2025 |
1.24% |
| Dec 31, 2024 |
-61.87% |
| Sep 30, 2024 |
1,780.59% |
| Jun 30, 2024 |
-40.54% |
| Mar 31, 2024 |
-40.64% |
| Dec 31, 2023 |
18.29% |
| Sep 30, 2023 |
-11.23% |
| Jun 30, 2023 |
-37.89% |
| Mar 31, 2023 |
-44.91% |
| Dec 31, 2022 |
413.14% |
| Sep 30, 2022 |
34.65% |
| Jun 30, 2022 |
-65.60% |
| Mar 31, 2022 |
-63.12% |
| Dec 31, 2021 |
36.18% |
| Sep 30, 2021 |
170.14% |
| Jun 30, 2021 |
77.40% |
| Mar 31, 2021 |
-39.84% |
| Dec 31, 2020 |
-49.68% |
